Magnesium Induced Developmental Neuroapoptosis
镁诱导发育性神经细胞凋亡
基本信息
- 批准号:7031336
- 负责人:
- 金额:$ 15.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-01-01 至 2010-12-31
- 项目状态:已结题
- 来源:
- 关键词:Bax gene /proteinage differenceapoptosisbiological modelsbraincalcium fluxchemopreventioncysteine endopeptidasesdevelopmental neurobiologydosagedrug adverse effectelectrophysiologyembryo /fetus toxicologyenzyme activitygenetically modified animalshippocampusimmunocytochemistrylaboratory mousemagnesiumneural degenerationneuropharmacologyneuroprotectantsneurotoxicologynewborn animalspharmacokineticssulfatestissue /cell culture
项目摘要
DESCRIPTION (provided by applicant): Recent studies have demonstrated widespread apoptotic neurodegeneration induced in the developing rodent brain by transient exposure to various agents that suppress neuronal activity, including NMDA glutamate antagonists, GABAA agonists, ethanol, and sodium channel blockers. The potential neurotoxic effects of MgSO4 have important public health implications due to its frequent use in obstetrics for preterm labor and pre-eclampsia/eclampsia resulting in fetal exposure during the synaptogenic period. Although Mg++ has been used in obstetrics for over 60 years, there is a lack of studies addressing the effects of increased Mg++ on the fetal brain. Mg++ has inhibitory properties at numerous cellular membrane receptors and ion channels, and can enhance surface charge screening effects. I have developed preliminary in vivo evidence that exposure to Mg++ can trigger apoptotic neurodegeneration in the developing rodent brain. In order to expand upon these in vivo findings, I have performed experiments exposing cultured hippocampal neurons to Mg++ and found similar neurodegenerative effects. I hypothesize that because of its intrinsic neuroinhibitory properties, Mg++ at non-physiologically high concentrations can suppress neuronal activity to a degree that is sufficient to precipitate neuroapoptosis. The Aims of the proposed research are: 1) to further characterize the neurodegenerative reaction induced in the developing mouse brain by Mg++ with respect to nature, pattern, pattern, time-course and age specificity; 2) determine dose-response parameters in vitro and in vivo, including lowest effective dose, and compare this with doses to which the developing human brain is sometimes exposed; 3) investigate mechanisms(s) and protective strategies in both in vitro and in vivo models. In the course of this work I will learn various histological methods, including electron microscopy and immunohistochemistry; stereologic techniques to quantitate neuronal injury; western blotting for evaluating biochemical pathways; transgenic animals, electrophysiology, and Ca++ and Mg++ imaging to aid in mechanistic studies; and pharmacological interventions to evaluate protective strategies. In addition, I will develop an understanding of neuroanatomy, neurochemistry, toxicokinetics and toxicodynamics, and statistical methods. My preceptors, Dr. John Olney, Dr. Eugene Johnson and Dr. Steve Mennerick, will provide close guidance and supervision during the proposed research period.
描述(由申请人提供):最近的研究表明,通过短暂接触各种抑制神经元活动的药物,包括 NMDA 谷氨酸拮抗剂、GABAA 激动剂、乙醇和钠通道阻滞剂,可在发育中的啮齿动物大脑中诱导广泛的细胞凋亡神经变性。 MgSO4 的潜在神经毒性作用具有重要的公共卫生影响,因为它在产科中经常用于早产和先兆子痫/子痫,导致胎儿在突触发生期间暴露。尽管 Mg++ 在产科中的应用已有 60 多年的历史,但缺乏研究探讨增加 Mg++ 对胎儿大脑的影响。 Mg++ 对许多细胞膜受体和离子通道具有抑制特性,可以增强表面电荷屏蔽作用。我已经开发出初步的体内证据,表明接触 Mg++ 可以引发发育中的啮齿动物大脑的细胞凋亡性神经变性。为了扩展这些体内发现,我进行了将培养的海马神经元暴露于 Mg++ 的实验,并发现了类似的神经退行性效应。我推测,由于其固有的神经抑制特性,非生理高浓度的 Mg++ 可以抑制神经元活动,达到足以促进神经细胞凋亡的程度。本研究的目的是: 1) 进一步表征 Mg++ 在发育中的小鼠大脑中诱导的神经退行性反应的性质、模式、模式、时间过程和年龄特异性; 2)确定体外和体内的剂量反应参数,包括最低有效剂量,并将其与发育中的人脑有时暴露的剂量进行比较; 3)研究体外和体内模型的机制和保护策略。在这项工作的过程中,我将学习各种组织学方法,包括电子显微镜和免疫组织化学;定量神经元损伤的立体学技术;用于评估生化途径的蛋白质印迹;转基因动物、电生理学以及 Ca++ 和 Mg++ 成像以辅助机制研究;和药物干预来评估保护策略。此外,我还将加深对神经解剖学、神经化学、毒代动力学和毒效动力学以及统计方法的了解。我的导师约翰·奥尔尼博士、尤金·约翰逊博士和史蒂夫·门纳里克博士将在拟议的研究期间提供密切的指导和监督。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM H DRIBBEN其他文献
WILLIAM H DRIBBEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM H DRIBBEN', 18)}}的其他基金
相似国自然基金
晶状体mtDNA氧化损伤修复与线粒体自噬的空间差异及其调控干预在年龄相关性白内障发病中的作用
- 批准号:82171038
- 批准年份:2021
- 资助金额:54 万元
- 项目类别:面上项目
基于脑电和眼动信号情绪识别的年龄差异、性别差异和文化差异研究
- 批准号:61976135
- 批准年份:2019
- 资助金额:61 万元
- 项目类别:面上项目
人类真实与错误记忆发展:基因-脑-行为研究
- 批准号:31571132
- 批准年份:2015
- 资助金额:64.0 万元
- 项目类别:面上项目
基于个体与家庭意愿的退休年龄政策研究:动态福利分析及其性别差异
- 批准号:71573052
- 批准年份:2015
- 资助金额:48.0 万元
- 项目类别:面上项目
信任的脑机制:个体差异与年龄发展
- 批准号:31400890
- 批准年份:2014
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Volatile anesthetics, calcium homeostasis and apoptosis
挥发性麻醉剂、钙稳态和细胞凋亡
- 批准号:
6859612 - 财政年份:2005
- 资助金额:
$ 15.65万 - 项目类别:
Volatile anesthetics, calcium homeostasis and apoptosis
挥发性麻醉剂、钙稳态和细胞凋亡
- 批准号:
7057847 - 财政年份:2005
- 资助金额:
$ 15.65万 - 项目类别:
Aging, Reperfusion, and Apoptosis:A Proteasome Approach
衰老、再灌注和细胞凋亡:蛋白酶体方法
- 批准号:
7020621 - 财政年份:2002
- 资助金额:
$ 15.65万 - 项目类别:
Aging, Reperfusion, and Apoptosis:A Proteasome Approach
衰老、再灌注和细胞凋亡:蛋白酶体方法
- 批准号:
6743130 - 财政年份:2002
- 资助金额:
$ 15.65万 - 项目类别:
Aging, Reperfusion, and Apoptosis:A Proteasome Approach
衰老、再灌注和细胞凋亡:蛋白酶体方法
- 批准号:
6625766 - 财政年份:2002
- 资助金额:
$ 15.65万 - 项目类别: